Cell>point | search
Click here to view Cell>point news from 60+ newspapers.
Bookmark or Share- Towards precision medicine: design considerations for nanozymes in ...Many current nanozymes have been designed considering that regulatory cell death (RCD) plays an important role in tissue development, internal environment stability and pathogenesis [].Many inorganic nanomaterials can induce apoptosis (Table 1), which is a type of regulated cell death caused by massive ROS production leading to intracellular oxidative stress accompanied by caspase-3/7 ...
- SEC.gov | Cell Point, LLC, Terry A. Colip, and Greg R. ColipThe SEC's complaint, filed on June 10, 2021, alleges that Cell>Point--a Colorado radiopharmaceutical company--and the Colips fraudulently offered and sold approximately $10 million in securities to at least 151 investors.
- SEC.gov | Cell>Point, LLC, Terry A. Colip, and Greg R. ColipThe Securities and Exchange Commission today charged Cell>Point, LLC, a Colorado radiopharmaceutical company, its CEO Greg Colip, and its CFO Terry Colip with fraudulently offering and selling approximately $10 million in securities to at least 151 investors.
- Small and long non-coding RNAs: Past, present, and future - Cell PressIn animals, there are at least three primary types of small RNAs: small interfering RNA (siRNA), PIWI-interacting RNA (piRNA), and microRNA (miRNA). 49,50,51,52,53,54 siRNAs are derived from long dsRNAs and are widespread in invertebrate species, where they suppress transposons and viruses.
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION, v. - SEC.govCell>Point, its Chief Executive Officer (“CEO”) Greg Colip, and its Chief Financial Officer (“CFO”) Terry Colip (with Greg Colip, the “Individual Defendants”) defrauded at least 151 investors into purchasing more than $10 million in Cell>Point securities.
More
